| |
 |
| Wednesday, 12/12/07 |
|
| 12:00 - 7:00 |
Registration |
| |
|
|
| Thursday, 12/13/07 |
|
| 7:00 - 5:00 |
Registration
|
| |
|
| 8:30 - 8:55 |
Opening Remarks
|
| |
|
| 8:55 - 9:15 |
Plenary Lecture 1
The worldwide overview: new results for systemic adjuvant therapies
Richard Peto, for the Early Breast Cancer Trialists' Collaborative Group
University of Oxford
Oxford, UNITED KINGDOM
|
| 9:15 - 10:30 |
General Session 1 (#10-14)
|
| |
|
| 10:30 - 12:00 |
Mini-Symposium 1
Stem Cells in Breast Cancer
|
| |
|
| 10:30 |
Breast Cancer Stem Cell: Targets for Prevention & Therapy
Max Wicha, MD
University of Michigan Comprehensive Cancer Center
Ann Arbor, MI |
| |
|
| 11:00 |
Cancer Stem Cells in Therapeutic Resistance and as Cellular Targets
Jeremy Rich, MD
Duke University Medical Center
Durham, NC |
| |
|
| 11:30 |
Epigenetic Stem Cell Signatures in Breast Cancer
Peter Laird, PhD
USC/Norris Comprehensive Cancer Center
Los Angeles, CA |
| |
|
| 12:00 - 1:00 |
Lunch
|
| |
|
| 1:00 - 1:30 |
Plenary Lecture 2
Radiation Treatment Planning for Breast Cancer: A Journey Through Time
Lori Pierce, MD
University of Michigan Medical School
Ann Arbor, MI
|
| |
|
| 1:30 - 3:45 |
General Session 2 (#21-29)
|
| |
|
| 3:45 - 5:00 |
Susan G. Komen for the Cure Brinker Awards for Scientific Distinction Lectures
|
| |
|
| 5:00 - 7:00 |
Poster Discussion 1 (#101-111)
|
| |
|
| 5:00 - 7:00 |
Poster Session 1 (#1001-1119)
|
| |
|
| 7:00 - 10:00 |
Brinker Awards for Scientific Distinction Reception and Dinner |
| |
|
|
| Friday, 12/14/07 |
|
| 6:45 - 5:00 |
Registration
|
| |
|
| 7:00 - 9:00 |
Poster Discussion 2 (#201-210)
|
| |
|
| 7:00 - 9:00 |
Poster Session 2 (#2001-2121)
|
| |
|
| 9:00 - 9:30 |
Plenary Lecture 3
Energy balance, insulin, and breast cancer
Michael Pollak, MD
McGill University
Montreal, CANADA
|
| |
|
| 9:30 - 11:15 |
General Session 3 (#31-37)
|
| |
|
| 11:15 - 12:00 |
William L. McGuire Memorial Lecture
Biomarking the oestrogen dependence of breast cancer
Mitchell Dowsett, PhD
Institute of Cancer Research/Royal Marsden NHS Trust
London, UNITED KINGDOM
|
| |
|
| 12:00 - 1:00 |
Lunch |
| |
|
| 12:30 - 1:45 |
Case Discussion 1
|
| |
|
| 2:00 - 3:30 |
Mini-Symposium 2
Women's Health Initiative: HRT and Other Issues
|
| |
|
| 2:00 |
The Women's Health Initiative Randomized Trials of Menopausal Hormone Therapy: Results and Impact on Clinical Practice
Rowan Chlebowski, MD, PhD
LA Biomedical Research Institute
Torrance, CA |
| |
|
| 2:30 |
A review of HRT and Breast Cancer in other epidemiologic studies
Jack Cuzick, PhD
Wolfson Institute of Preventive Medicine
London, UNITED KINGDOM |
| |
|
| 3:00 |
Understanding Changes in Breast Cancer Incidence. Interactions Between
Epidemiological and Clinical Trial Evidence
Peter Ravdin, MD, PhD
MD Anderson Cancer Center
Houston, TX |
| |
|
| 3:30 - 5:00 |
General Session 4 (#41-46)
|
| |
|
| 5:00 - 7:00 |
Poster Discussion 3 (#301-310)
|
| |
|
| 5:00 - 7:00 |
Poster Session 3 (#3001-3120) |
| |
|
| 7:00 - 8:00 |
Late-breaking Session (#47-50) |
| |
|
|
| Saturday, 12/15/07 |
|
| 6:45 - 5:00 |
Registration
|
| |
|
| 7:00 - 9:00 |
Poster Discussion 4 (#401-409)
|
| |
|
| 7:00 - 9:00 |
Poster Session 4 (#4001-4117)
|
| |
|
| 9:00 - 9:30 |
Plenary Lecture 4
Multidisciplinary guidelines across the continuum of care: the NCCN experience
Robert Carlson, MD
Stanford University
Stanford, CA
|
| |
|
| 9:30 - 10:00 |
Plenary Lecture 5
Symptom management in breast cancer survivors
Charles Loprinzi, MD
Mayo Clinic
Rochester, MN
|
| |
|
| 10:00 - 11:00 |
General Session 5 (#51-54)
|
| |
|
| 11:00 - 12:00 |
Mini-Symposium 3
Molecular Imaging for Breast Cancer Diagnostics
|
| |
|
| 11:00 |
Development of Non-Invasive Optical Methods for Breast Cancer Detection and Clinical Management
Bruce J. Tromberg, PhD
Beckman Laser Institute
Irvine, CA |
| |
|
| 11:30 |
Functional Breast Imaging: State of the PET
Eric L. Rosen, MD
Seattle Cancer Care Alliance
Seattle, WA |
| |
|
| 12:00 - 1:00 |
Lunch
|
| |
|
| 12:30 - 1:45 |
Case Discussion 2
|
| |
|
| 2:00 - 3:30 |
Mini-Symposium 4
Systems Biology and Targeting the HER Network in the Treatment of Breast Cancer
|
| |
|
| 2:00 |
HER pathways in the context of systems biology and integrating networks
Yosef Yarden, PhD
The Weizmann Institute of Science
Rehovat, ISRAEL |
| |
|
| 2:30 |
Novel strategies for HER-targeted therapy and mechanisms of resistance
C. Kent Osborne, MD
Baylor College of Medicine
Houston, TX |
| |
|
| 3:00 |
Novel experimental global approaches in studies of signaling networks and therapy resistance
René Bernards, PhD
The Netherlands Cancer Institute
Amsterdam, NETHERLANDS |
| |
|
| 3:30 - 5:00 |
General Session 6 (#61-66)
|
| |
|
| 5:00 - 7:00 |
Poster Discussion 5 (#501-511)
|
| |
|
| 5:00 - 7:00 |
Poster Session 5 (#5001-5119)
|
| |
|
| 7:00 - 10:00 |
Satellite Symposium
Controversies in Adjuvant Endocrine Therapy for Breast Cancer |
| |
|
|
| Sunday, 12/16/07 |
|
| 6:45 - 10:00 |
Registration
|
| |
|
| 7:00 - 9:00 |
Poster Session 6 (#6001-6119)
|
| |
|
| 9:00 - 12:00 |
General Session 7 (#71-82)
|
| |
|
| 12:00 |
Adjournment |
| |
Home
Registration
Schedule at a Glance
